

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproduci⦠read more
Healthcare
Medical Devices
5 years
USD
Exclusive to Premium users
$10.11
Price-1.37%
-$0.14
$120.759m
Small
-
Premium
Premium
-43.5%
EBITDA Margin-12.7%
Net Profit Margin-36.4%
Free Cash Flow Margin$58.364m
+9.1%
1y CAGR+18.4%
3y CAGR+14.5%
5y CAGR-$49.313m
-57.0%
1y CAGR-49.2%
3y CAGR-37.2%
5y CAGR-$4.21
-54.2%
1y CAGR-43.1%
3y CAGR-30.7%
5y CAGR-$9.268m
$70.414m
Assets$79.682m
Liabilities$2.332m
Debt3.3%
-0.2x
Debt to EBITDA-$5.232m
-115.2%
1y CAGR-2.0%
3y CAGR-16.6%
5y CAGR